You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Sotagliflozin, the first dual SGLT inhibitor: current outlook and perspectives
|
|---|---|
| Published in |
Cardiovascular Diabetology, February 2019
|
| DOI | 10.1186/s12933-019-0828-y |
| Pubmed ID | |
| Authors |
Chiara Maria Assunta Cefalo, Francesca Cinti, Simona Moffa, Flavia Impronta, Gian Pio Sorice, Teresa Mezza, Alfredo Pontecorvi, Andrea Giaccari |
X Demographics
The data shown below were collected from the profiles of 71 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Spain | 21 | 30% |
| United Kingdom | 6 | 8% |
| Mexico | 6 | 8% |
| United States | 4 | 6% |
| Ecuador | 2 | 3% |
| Chile | 1 | 1% |
| Venezuela, Bolivarian Republic of | 1 | 1% |
| Uruguay | 1 | 1% |
| Norway | 1 | 1% |
| Other | 6 | 8% |
| Unknown | 22 | 31% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 46 | 65% |
| Practitioners (doctors, other healthcare professionals) | 14 | 20% |
| Scientists | 8 | 11% |
| Science communicators (journalists, bloggers, editors) | 3 | 4% |
Mendeley readers
The data shown below were compiled from readership statistics for 164 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 164 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 26 | 16% |
| Researcher | 18 | 11% |
| Student > Master | 16 | 10% |
| Student > Ph. D. Student | 12 | 7% |
| Student > Doctoral Student | 8 | 5% |
| Other | 32 | 20% |
| Unknown | 52 | 32% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 48 | 29% |
| Pharmacology, Toxicology and Pharmaceutical Science | 16 | 10% |
| Biochemistry, Genetics and Molecular Biology | 11 | 7% |
| Chemistry | 7 | 4% |
| Agricultural and Biological Sciences | 6 | 4% |
| Other | 19 | 12% |
| Unknown | 57 | 35% |
Attention Score in Context
This research output has an Altmetric Attention Score of 61. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 June 2023.
All research outputs
#712,185
of 25,732,188 outputs
Outputs from Cardiovascular Diabetology
#31
of 1,688 outputs
Outputs of similar age
#16,558
of 368,562 outputs
Outputs of similar age from Cardiovascular Diabetology
#1
of 20 outputs
Altmetric has tracked 25,732,188 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 97th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 1,688 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.6. This one has done particularly well, scoring higher than 98% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 368,562 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 95% of its contemporaries.
We're also able to compare this research output to 20 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 95% of its contemporaries.